GRIPS CUSTOMERS & RESEARCH PARTNERS
I'll verify whether ToCAD is publicly traded before drafting the overview.The ticker "TOCA" belongs to Tocagen, a biopharmaceutical company, not ToCAD. I'm not able to confirm a ticker for ToCAD, so I'll omit it. Based on Grips Intelligence data spanning January 1 to June 30, 2026, ToCAD's tracked in-store performance saw overall revenue grow 12.8% across the period, with the average product price holding steady at $48.99. During the April–June 2026 timeframe, monthly revenue climbed 47.0% versus the prior month, marking the brand's strongest momentum of the period. According to Grips Intelligence, the average price remained flat at 0.0% change, signaling that growth was driven by volume rather than pricing. All of ToCAD's tracked offline revenue flowed through a single channel, Best Buy, which accounted for 100% of its share year-to-date. This channel concentration underscores both a key strength and a notable dependency in ToCAD's retail footprint.
OVER TIME
Over the last three months, revenue on tracked channels has grew by 13% from Apr to Jun.
OVER TIME
Over the last three months, average selling price on tracked channels has increased by 0% from Apr to Jun.
REVENUE SHARE
Revenue distribution across product categories for ToCAD on Best Buy.
REVENUE SHARE
Revenue distribution across tracked channels for ToCAD.
BY REVENUE
$149.99
Price
Revenue
$329.99
Price
Revenue
$89.99
Price
Revenue
Get access to full product performance analysis